CA Stock MarketDetailed Quotes

ZYUS ZYUS Life Sciences Corp

Watchlist

0.800
0.0000.00%

15min DelayMarket Closed Nov 14 16:00 ET

59.49MMarket Cap-1454P/E (TTM)

ZYUS Life Sciences Corp Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

91.07%-443K

-61.74%-2.64M

-88.13%-18.01M

-54.56%-2.82M

-310.54%-8.61M

-78.22%-4.96M

43.23%-1.63M

43.21%-9.57M

-1.82M

-2.1M

Net income from continuing operations

46.99%-4.81M

30.98%-3.34M

-72.73%-42.59M

-308.49%-24.49M

43.12%-4.19M

-55.56%-9.08M

11.36%-4.84M

-5.12%-24.66M

---5.99M

---7.37M

Operating gains losses

-102.25%-19K

-97.56%12K

79.04%1.15M

-100.67%-8K

-98.86%-175K

178.88%845K

164.35%491K

145.32%644K

--1.19M

---88K

Depreciation and amortization

20.76%727K

-22.39%721K

-23.21%3.11M

5.43%815K

-30.28%760K

-44.62%602K

-15.16%929K

7.01%4.05M

--773K

--1.09M

Asset impairment expenditure

-33.33%4K

500.00%6K

890.04%24.95M

31,828.21%24.9M

-98.21%38K

500.00%6K

-99.69%1K

--2.52M

--78K

--2.12M

Remuneration paid in stock

1,408.33%181K

144.44%44K

144.04%266K

1,136.84%235K

-88.89%1K

1,300.00%12K

-78.05%18K

-82.45%109K

--19K

--9K

Deferred tax

19.05%-17K

-6.25%-17K

-9,982.76%-5.85M

-578,900.00%-5.79M

-23.53%-21K

-10.53%-21K

23.81%-16K

50.43%-58K

---1K

---17K

Other non cashItems

-98.69%52K

-89.00%165K

12.69%5.99M

-80.29%415K

-80.90%123K

129.54%3.96M

77.51%1.5M

115.92%5.32M

--2.11M

--644K

Change In working capital

368.41%3.44M

-181.91%-231K

-283.81%-4.81M

1,522.35%1.21M

-392.03%-5.02M

-2,230.91%-1.28M

-72.86%282K

20.75%2.62M

---85K

--1.72M

-Change in receivables

-176.58%-307K

---162K

-430.48%-347K

-178.36%-105K

-154.36%-131K

50.45%-111K

--0

-67.89%105K

--134K

--241K

-Change in inventory

113.16%162K

-421.82%-177K

-104.67%-21K

-359.77%-226K

-68.64%74K

-49.67%76K

329.17%55K

364.71%450K

--87K

--236K

-Change in prepaid assets

-29.65%223K

219.73%176K

370.59%736K

550.80%1.13M

-819.67%-561K

220.08%317K

-148.51%-147K

-435.80%-272K

---250K

---61K

-Change in payables and accrued expense

215.71%1.78M

-194.65%-354K

-319.09%-5.12M

980.36%493K

-441.33%-4.45M

-643.97%-1.53M

-53.60%374K

20.97%2.34M

---56K

--1.3M

-Change in other current assets

5,393.33%1.59M

--286K

---64K

---80K

--46K

---30K

--0

Interest paid (cash flow from operating activities)

----

-98.25%-226K

-223.33%-111K

----

87.33%-114K

--90K

---204K

Cash from discontinued investing activities

Operating cash flow

91.07%-443K

-61.74%-2.64M

-88.13%-18.01M

-54.56%-2.82M

-310.54%-8.61M

-78.22%-4.96M

43.23%-1.63M

43.21%-9.57M

---1.82M

---2.1M

Investing cash flow

Cash flow from continuing investing activities

29.17%-34K

883.78%4.64M

36.42%-192K

60.67%-35K

3,133.95%4.92M

-23.08%-48K

88.13%-592K

-302K

-89K

Net PPE purchase and sale

--0

29.17%-34K

49.82%-281K

28.89%-192K

60.67%-35K

96.30%-6K

-23.08%-48K

88.77%-560K

---270K

---89K

Net business purchase and sale

----

15,478.13%4.92M

--0

----

---32K

--0

Cash from discontinued investing activities

Investing cash flow

--0

29.17%-34K

883.78%4.64M

36.42%-192K

60.67%-35K

3,133.95%4.92M

-23.08%-48K

88.13%-592K

---302K

---89K

Financing cash flow

Cash flow from continuing financing activities

-97.99%314K

-114.27%-341K

78.00%17.14M

-115.31%-334K

-126.10%-551K

458.16%15.63M

-5.72%2.39M

-34.08%9.63M

2.18M

2.11M

Net issuance payments of debt

-97.99%314K

-114.27%-341K

-113.81%-1.31M

-115.31%-334K

-999.76%-18.99M

458.16%15.63M

1.27%2.39M

-18.49%9.45M

--2.18M

--2.11M

Net common stock issuance

----

--0

----

2,087.50%175K

--0

Net other financing activities

----

--18.44M

--0

----

Cash from discontinued financing activities

Financing cash flow

-97.99%314K

-114.27%-341K

78.00%17.14M

-115.31%-334K

-126.10%-551K

458.16%15.63M

-5.72%2.39M

-34.08%9.63M

--2.18M

--2.11M

Net cash flow

Beginning cash position

4.66%965K

1,776.42%3.98M

-71.73%212K

4,653.25%7.32M

7,141.67%16.51M

147.85%922K

-71.73%212K

-90.62%750K

--154K

--228K

Current changes in cash

-100.83%-129K

-524.37%-3.01M

800.00%3.77M

-5,862.07%-3.34M

-12,320.27%-9.19M

10,925.69%15.59M

287.83%710K

92.57%-538K

--58K

---74K

End cash Position

-94.94%836K

4.66%965K

1,776.42%3.98M

4,653.25%7.32M

7,141.67%16.51M

147.85%922K

-71.73%212K

--212K

--154K

Free cash from

91.08%-443K

-59.14%-2.67M

-80.51%-18.29M

-43.79%-3.01M

-295.42%-8.64M

-68.62%-4.97M

42.34%-1.68M

53.62%-10.13M

---2.09M

---2.19M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	91.07%-443K	-61.74%-2.64M	-88.13%-18.01M	-54.56%-2.82M	-310.54%-8.61M	-78.22%-4.96M	43.23%-1.63M	43.21%-9.57M	-1.82M	-2.1M
Net income from continuing operations	46.99%-4.81M	30.98%-3.34M	-72.73%-42.59M	-308.49%-24.49M	43.12%-4.19M	-55.56%-9.08M	11.36%-4.84M	-5.12%-24.66M	---5.99M	---7.37M
Operating gains losses	-102.25%-19K	-97.56%12K	79.04%1.15M	-100.67%-8K	-98.86%-175K	178.88%845K	164.35%491K	145.32%644K	--1.19M	---88K
Depreciation and amortization	20.76%727K	-22.39%721K	-23.21%3.11M	5.43%815K	-30.28%760K	-44.62%602K	-15.16%929K	7.01%4.05M	--773K	--1.09M
Asset impairment expenditure	-33.33%4K	500.00%6K	890.04%24.95M	31,828.21%24.9M	-98.21%38K	500.00%6K	-99.69%1K	--2.52M	--78K	--2.12M
Remuneration paid in stock	1,408.33%181K	144.44%44K	144.04%266K	1,136.84%235K	-88.89%1K	1,300.00%12K	-78.05%18K	-82.45%109K	--19K	--9K
Deferred tax	19.05%-17K	-6.25%-17K	-9,982.76%-5.85M	-578,900.00%-5.79M	-23.53%-21K	-10.53%-21K	23.81%-16K	50.43%-58K	---1K	---17K
Other non cashItems	-98.69%52K	-89.00%165K	12.69%5.99M	-80.29%415K	-80.90%123K	129.54%3.96M	77.51%1.5M	115.92%5.32M	--2.11M	--644K
Change In working capital	368.41%3.44M	-181.91%-231K	-283.81%-4.81M	1,522.35%1.21M	-392.03%-5.02M	-2,230.91%-1.28M	-72.86%282K	20.75%2.62M	---85K	--1.72M
-Change in receivables	-176.58%-307K	---162K	-430.48%-347K	-178.36%-105K	-154.36%-131K	50.45%-111K	--0	-67.89%105K	--134K	--241K
-Change in inventory	113.16%162K	-421.82%-177K	-104.67%-21K	-359.77%-226K	-68.64%74K	-49.67%76K	329.17%55K	364.71%450K	--87K	--236K
-Change in prepaid assets	-29.65%223K	219.73%176K	370.59%736K	550.80%1.13M	-819.67%-561K	220.08%317K	-148.51%-147K	-435.80%-272K	---250K	---61K
-Change in payables and accrued expense	215.71%1.78M	-194.65%-354K	-319.09%-5.12M	980.36%493K	-441.33%-4.45M	-643.97%-1.53M	-53.60%374K	20.97%2.34M	---56K	--1.3M
-Change in other current assets	5,393.33%1.59M	--286K	---64K	---80K	--46K	---30K	--0	--0	--0	--0
Interest paid (cash flow from operating activities)	----	----	-98.25%-226K	-223.33%-111K	----	----	----	87.33%-114K	--90K	---204K
Cash from discontinued investing activities
Operating cash flow	91.07%-443K	-61.74%-2.64M	-88.13%-18.01M	-54.56%-2.82M	-310.54%-8.61M	-78.22%-4.96M	43.23%-1.63M	43.21%-9.57M	---1.82M	---2.1M
Investing cash flow
Cash flow from continuing investing activities	0	29.17%-34K	883.78%4.64M	36.42%-192K	60.67%-35K	3,133.95%4.92M	-23.08%-48K	88.13%-592K	-302K	-89K
Net PPE purchase and sale	--0	29.17%-34K	49.82%-281K	28.89%-192K	60.67%-35K	96.30%-6K	-23.08%-48K	88.77%-560K	---270K	---89K
Net business purchase and sale	----	----	15,478.13%4.92M	--0	--0	----	----	---32K	---32K	--0
Cash from discontinued investing activities
Investing cash flow	--0	29.17%-34K	883.78%4.64M	36.42%-192K	60.67%-35K	3,133.95%4.92M	-23.08%-48K	88.13%-592K	---302K	---89K
Financing cash flow
Cash flow from continuing financing activities	-97.99%314K	-114.27%-341K	78.00%17.14M	-115.31%-334K	-126.10%-551K	458.16%15.63M	-5.72%2.39M	-34.08%9.63M	2.18M	2.11M
Net issuance payments of debt	-97.99%314K	-114.27%-341K	-113.81%-1.31M	-115.31%-334K	-999.76%-18.99M	458.16%15.63M	1.27%2.39M	-18.49%9.45M	--2.18M	--2.11M
Net common stock issuance	----	----	--0	--0	----	----	----	2,087.50%175K	--0	--0
Net other financing activities	----	----	--18.44M	--0	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-97.99%314K	-114.27%-341K	78.00%17.14M	-115.31%-334K	-126.10%-551K	458.16%15.63M	-5.72%2.39M	-34.08%9.63M	--2.18M	--2.11M
Net cash flow
Beginning cash position	4.66%965K	1,776.42%3.98M	-71.73%212K	4,653.25%7.32M	7,141.67%16.51M	147.85%922K	-71.73%212K	-90.62%750K	--154K	--228K
Current changes in cash	-100.83%-129K	-524.37%-3.01M	800.00%3.77M	-5,862.07%-3.34M	-12,320.27%-9.19M	10,925.69%15.59M	287.83%710K	92.57%-538K	--58K	---74K
End cash Position	-94.94%836K	4.66%965K	1,776.42%3.98M	1,776.42%3.98M	4,653.25%7.32M	7,141.67%16.51M	147.85%922K	-71.73%212K	--212K	--154K
Free cash from	91.08%-443K	-59.14%-2.67M	-80.51%-18.29M	-43.79%-3.01M	-295.42%-8.64M	-68.62%-4.97M	42.34%-1.68M	53.62%-10.13M	---2.09M	---2.19M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

ZYUS ZYUS Life Sciences Corp

ZYUS Life Sciences Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow